The Effect of Yagya on Stress, Anxiety and Depression in Women

Anuradha Gupta

doi:10.63300/irjoyas403.052026.05

Authors

Ms. Anuradha Gupta Assistant Professor, Department of Yoga Science, University of Patanjali, Haridwar, Uttarakhand-249405, India. Author

DOI:

https://doi.org/10.63300/irjoyas403.052026.05

Keywords:

Anxiety, Depression, Stress, Women, Yagya

Abstract

Background

A traditional Indian treatment method known as Yagya therapy refers to holistic health care. Modern research on this ancient wisdom, known as "Yagya," is showing promising results as a therapeutic approach for treating mental problems as well as for promoting a more stable state of mind. The current study looked examined how yagya affected stress, anxiety and depression (DAS) in women.

Method

This study is a pre‑post research design carried out on 258 women, Haridwar having the mean age of 43.58±12.17 years. To collect the data, an established questionnaire of DASS‑42 was used. Swami Dayananda’s established Yagya method is followed before and after Yagya practices among the women for a period of 7 days at Patanjali yoga gram, Haridwar. We have used established 10 medicinal plants mixed samagri or natural products. The data is analysed by using Generalized Linear Method – RMANOVA, SPSS -25 version.

Results and Discussion

The result shows that there is a decrease in DAS with Yagya intervention from 61.52± 30.79 to 23.66±17.87. The Yagya intervention shows a strong significance at p<0.0001.

Conclusion

It may be concluded that Yagya intervention is exclusively tested for women in the age group from 23 to 68 years and found to be encouraging. We may have to replicate the same in different environmental conditions.

Downloads

Download data is not yet available.

Author Biography

Ms. Anuradha Gupta, Assistant Professor, Department of Yoga Science, University of Patanjali, Haridwar, Uttarakhand-249405, India.

Ms. Anuradha Gupta^*, Assistant Professor, Department of Yoga Science, University of Patanjali, Haridwar, Uttarakhand-249405, India.

*Corresponding Author: dranuradha.gupta@uop.edu.in.

References

[1]. Hare-Mustin, R. T., & Marecek, J. (1988). The meaning of difference: Gender theory, postmodernism, and psychology. American psychologist, 43(6), 455.

[2]. World Health Organization. (2001). The World Health Report 2001: Mental health: new understanding, new hope.

[3]. Eaton, N. R., Keyes, K. M., Krueger, R. F., Balsis, S., Skodol, A. E., Markon, K. E., ... & Hasin, D. S. (2012). An invariant dimensional liability model of gender differences in mental disorder prevalence: evidence from a national sample. Journal of abnormal psychology, 121(1), 282.

[4]. Malhotra, S., & Shah, R. (2015). Women and mental health in India: An overview. Indian journal of psychiatry, 57(Suppl 2), S205.

[5]. Kornstein, S. G., & Clayton, A. H. (Eds.). (2004). Women's mental health: a comprehensive textbook. Guilford Press.

[6]. Thara, R., & Patel, V. (2001). Women? s and mental health. In Regional Health Forum (Vol. 5, pp. 24-34).

[7]. GBD 2019 Mental Disorders Collaborators. (2022). Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet Psychiatry, 9(2), 137-150.

[8]. Choudhary, R., Goswami, L., & Kothiyal, P. (2013). Brain Drug Delivery of Nanoparticles by Nasal Route for the treatment of Depression. BRAIN, 3, 0.

[9]. Pathak, V. (2018). Nasal delivery—A promising route of drug delivery to the brain: Scientific considerations. Drug Development & Delivery, 18, 63-68.

[10]. Vyas, T. K., Shahiwala, A., Marathe, S., & Misra, A. (2005). Intranasal drug delivery for brain targeting. Current drug delivery, 2(2), 165-175.

[11]. Kashyap, K., & Shukla, R. (2019). Drug delivery and targeting to the brain through nasal route: mechanisms, applications and challenges. Current Drug Delivery, 16(10), 887-901.

[12]. Lovibond, P. F., & Lovibond, S. H. (1995). The structure of negative emotional states: Comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behaviour research and therapy, 33(3), 335-343.

[13]. Clark, L. A. & Watson, D. (1990). Theoretical and empirical issues in differentiating depression from anxiety. In Becker, J. & Kleinman, A. (Eds), Advances in mood disorders, Vol. 1. Psychosocial aspects of depression. Erlbaum, Hillsdale, N.J.

[14]. Singh, S., Rahat, S., Rai, V. K., & Rai, S. (2022). Could Agnihotra yagya have any role in the prevention and management of epidemics as COVID-19: A scientific perspective. Journal of Ayurveda, 16(3), 236.

[15]. Rastogi, R., Tandon, N., Sagar, S., Singh, B., Rajeshwari, T., Rastogi, M., ... & Dhamija, L. (2022). Analytical study of the effect of agnihotra on AQI and its psycho-social impacts: a perspective amidst second wave of pandemic challenges in National Capital Region of Indian subcontinents. International Journal of Indian Culture and Business Management, 26(2), 145-165.

[16]. Trivedi, D. (2020). Aromatherapy and Yagya Therapy for Mental Health. Interdisciplinary Journal of Yagya Research, 3(2), 29-41.

[17]. Ford, D. E., & Erlinger, T. P. (2004). Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Archives of internal medicine, 164(9), 1010-1014.

[18]. Cyranowski, J. M., Frank, E., Young, E., & Shear, M. K. (2000). Adolescent onset of the gender difference in lifetime rates of major depression: a theoretical model. Archives of general psychiatry, 57(1), 21-27.

[19]. Parry, B. L. (2000). Hormonal basis of mood disorders in women. Gender and its effects on psychopathology, 3-22.